Dr Kyle Taylor net worth
Quick answer
Dr Kyle Taylor's estimated net worth is $22K (range $16K – $34K) as of 2026. Dr Kyle Taylor is Founder at TAXA Biotechnologies. TAXA Biotechnologies valuation.
Dr Kyle Taylor is Founder at TAXA Biotechnologies (YC S14). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Inactive
- Education: PhD in Bioengineering from University of California, Berkeley
- Region: United States of America
- Industries: Healthcare, Consumer Health and Wellness
- Team size: 2
- Website: http://www.taxa.com
Who is Dr Kyle Taylor?
Dr. Kyle Taylor is a founder at TAXA Biotechnologies and participated in Y Combinator's S14 cohort.
Highlights:
- University of California, Berkeley
- Harvard University
- Developed innovative biotechnological solutions
About TAXA Biotechnologies
The TAXA platform has been specifically designed to enable anyone to perform metabolic engineering of plants without stepping into a lab. We provide access to protein engineering, DNA assembly, transient experiments and stable transformation as a service. The best thing is that anything "Powered by TAXA" is designed to be free from expensive regulatory approval, meaning the products are available for sale or...
FAQ: Dr Kyle Taylor net worth and TAXA Biotechnologies valuation
What is Dr Kyle Taylor's net worth?
Dr Kyle Taylor's estimated net worth is $22K (range $16K – $34K) as of 2026. Dr Kyle Taylor is Founder at TAXA Biotechnologies. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is TAXA Biotechnologies valuation?
TAXA Biotechnologies's estimated valuation on Entrepreneurial Check is $1.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Dr Kyle Taylor's role?
Dr Kyle Taylor is Founder at TAXA Biotechnologies, a Y Combinator-backed startup (batch S14).